 |
Back to News
Cyanotech Corporation Reports First Quarter Fiscal 2006 Financial Results; Reports Net Income of $153,000 on Sales of $3,029,000
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Aug. 11, 2005--Cyanotech Corporation (Nasdaq:CYAN), a world leader in producing high-value natural products from microalgae, today announced results for the first fiscal quarter, ended June 30, 2005.
For the three months ended June 30, 2005 the Company reported net sales of $3,029,000, an increase of $322,000 or 12%, compared to sales of $2,707,000 reported for the comparable period of the prior fiscal year. Gross profit for the first quarter of fiscal 2006 was $1,025,000, an increase of 16% from gross profit of $887,000 for the same period last year. The Company reported gross profit margin of 34% for the current year quarter, a slight increase from gross profit of 33% reported for the first quarter of the prior fiscal year.
Operating expenses for the first quarter of fiscal 2006 were $817,000, an increase of 13% from the $726,000 reported for the comparable period of the prior fiscal year, General and Administrative and Sales and Marketing expense both increased; these increases were partially offset by decreases in research and development expense. Income from operations amounted to $208,000, a 29% increase from income from operations of $161,000 reported for the comparable quarter of the prior year. Other expense, net for the first quarter of fiscal 2006 was $50,000, an increase of 52% from other expense, net of $33,000 reported for the comparable quarter of the prior fiscal year. The Company reported net income of $153,000, or $0.01 per diluted share, an increase from net income of $113,000, or $0.01 per diluted share, for the comparable quarter of the prior fiscal year.
"The first quarter of fiscal 2006 was characterized by stronger sales of all of our products compared to the first quarter of fiscal 2005 and the prior consecutive quarter," said Gerald R. Cysewski, Ph.D., Chairman, President and Chief Executive Officer. "We have been cultivating Spirulina Pacifica(R) for 20 years at our Kona facility and our focus on quality, product safety and high value has attracted customers who desire this high quality product. In turn, this translates into high demand for our Spirulina products. Our BioAstin(R) anti-inflammatory antioxidant has the same reputation for quality, safety and high value and as it is a relatively new product, we are excited about its potential for increased sales. Contributing to our results for this quarter were increased sales of NatuRose(R) natural astaxanthin to the Japan aquaculture market. We remain cautious about the recovery rate of that market following the disruption caused by a severe typhoon season a year ago. With the completion of our production facility upgrade last fiscal year we are now able to better adapt our cultivation and processing according to market trends. Our results may vary from quarter to quarter, but our goal is to achieve annual revenue growth and increase profitability."
About Cyanotech
Cyanotech Corporation, a world leader in microalgal technology, produces BioAstin(R) natural astaxanthin and Spirulina Pacifica(R) -- all-natural, functional nutrients that enhance human health and nutrition, providing significant antioxidant, anti-inflammatory and immune response benefits. The Company's other compounds, such as NatuRose(R) natural astaxanthin, promote animal nutrition and health, primarily in aquaculture. Cyanotech extracts these compounds from microalgae grown at its 90-acre facility in Hawaii using proprietary processes, and distributes them to nutraceutical, nutritional supplement, cosmeceutical and aquaculture feed makers and marketers worldwide. Corporate data and product information are available at www.cyanotech.com.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995
Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, forecasts of sales in future periods, changes in sales levels to our largest customers, weather patterns, production problems caused by contamination, risks associated with the acceptance of new products, competition, foreign exchange fluctuations, government regulation, and other factors more fully detailed in the Company's recent Form 10-Q and annual form 10-K filings with the Securities and Exchange Commission.
Cyanotech Corporation will hold a conference call on Thursday, August 11, 2005 at 5:30 p.m. Eastern Time to be broadcast live over the Internet. It can be accessed by all interested parties by linking through the Investor Broadcast Network's VCall website at www.vcall.com or through Cyanotech's website, http://www.cyanotech.com. To access the simultaneous webcast on the Cyanotech site, select the Recent News section from Cyanotech's home page. Click on the announcement entitled, "Cyanotech Announces Fiscal Year 2006 First Quarter Financial Results Webcast August 11, 2005." To listen to the live call, please go to either website at least 15 minutes prior to the start of the call to register, download, and install any necessary audio software. For those who are not able to listen to the live broadcast, a replay will be available shortly after the call and will be archived for a period of one calendar year.
CYANOTECH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
June 30,
2005 2004
------------ ------------
NET SALES $ 3,029 $ 2,707
COST OF PRODUCT SALES 2,004 1,820
------------ ------------
Gross Profit 1,025 887
------------ ------------
OPERATING EXPENSES:
Research and development 46 65
General and administrative 438 367
Sales and marketing 333 294
------------ ------------
Total operating expenses 817 726
------------ ------------
Income from operations 208 161
------------ ------------
OTHER INCOME (EXPENSE):
Interest income 15 8
Interest expense (55) (39)
Other expense, net (10) (2)
------------ ------------
Total other expense, net (50) (33)
------------ ------------
Income (loss) before income taxes 158 128
INCOME TAX EXPENSE 5 15
------------ ------------
NET INCOME $ 153 $ 113
============ ============
NET INCOME PER SHARE:
Basic $ 0.01 $ 0.01
============ ============
Diluted $ 0.01 $ 0.01
============ ============
SHARES USED IN CALCULATION OF
NET INCOME PER SHARE:
Basic 20,896 20,736
============ ============
Diluted 21,019 20,992
============ ============
COMPREHENSIVE INCOME :
Net income $ 153 $ 113
Other comprehensive income (loss) (2) 14
------------ ------------
$ 151 $ 127
============ ============
CYANOTECH CORPORATION
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands except per share amounts)
(Unaudited)
June 30, March 31,
2005 2005
------------ ------------
ASSETS
Current assets:
Cash and cash equivalents $ 1,743 $ 2,005
Short-term investments 1,000 1,000
Accounts receivable, net 2,371 2,069
Refundable income taxes 51 97
Inventories 1,589 1,565
Prepaid expenses and other 168 85
------------ ------------
Total current assets 6,922 6,821
Equipment and leasehold
improvements, net 10,877 11,174
Other assets 541 547
------------ ------------
Total assets $ 18,340 $ 18,542
============ ============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current maturities of long-term debt $ 354 $ 355
Accounts payable 576 977
Accrued expenses 521 387
------------ ------------
Total current liabilities 1,451 1,719
Long-term debt, excluding
current maturities 1,658 1,743
------------ ------------
Total liabilities 3,109 3,462
------------ ------------
Stockholders' equity:
Common stock of $0.005 par value,
shares authorized 30,000,000;
20,896,265 shares issued and
outstanding at June 30, 2005
and March 31, 2005 104 104
Additional paid-in capital 27,298 27,298
Accumulated other comprehensive
income
- foreign currency translation
adjustments 25 27
Accumulated deficit (12,196) (12,349)
------------ ------------
Total stockholders' equity 15,231 15,080
------------ ------------
Total liabilities and stockholders' equity $ 18,340 $ 18,542
============ ============
CONTACT: Cyanotech Corporation
Jeffrey H. Sakamoto, 808-326-1353
jsakamoto@cyanotech.com
or
Investors and Media:
Russell Communications Group
Bruce Russell, 310-559-4955 x101
brucerussell@ruscom.com
SOURCE: Cyanotech Corporation
|
|
